Showing results (271-280 of 432) with videos related to
Sort By:
Pageof 44
JAMA Dermatology|March 12, 2025
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet SyndromeChloé Grolleau, Maxime Battistella, Eve Zakine, et al.Blood|February 27, 2019
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel A Sanz, Pierre Fenaux, Martin S Tallman, et al.Leukemia Research|November 17, 2012
Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromesCarole Le Pogam, Patricia Krief, Stephanie Beurlet, et al.Blood Advances|January 17, 2024
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trialGail J Roboz, Guillermo Sanz, Elizabeth A Griffiths, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating AgentsValeria Santini, Antonio Almeida, Aristoteles Giagounidis, et al.The Lancet. Haematology|February 5, 2025
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort studyHege Kristin Gravdahl Garelius, Timothy Bagguley, Adele Taylor, et al.Nature Communications|February 3, 2023
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylationMaxime Boy, Valeria Bisio, Lin-Pierre Zhao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2020
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II StudyDavid P Steensma, Pierre Fenaux, Koen Van Eygen, et al.Cancer Research|December 20, 2007
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasiaNader Omidvar, Scott Kogan, Stephanie Beurlet, et al.Leukemia & Lymphoma|August 26, 2017
Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+)José Falantes, Lisa Pleyer, Sylvain Thépot, et al.Pageof 44